about
Redistribution of DAT/α-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's diseaseSNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's diseaseMitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases.Late-onset Parkinsonism in NFκB/c-Rel-deficient miceFrom α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease.The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues.Review: Parkinson's disease: from synaptic loss to connectome dysfunction.Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure.The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy.Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease.Combined treatment with atorvastatin and minocycline suppresses severity of EAE.Mild Inflammatory Profile without Gliosis in the c-Rel Deficient Mouse Modeling a Late-Onset Parkinsonism.Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose DeprivationBeta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway.α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons.Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice.Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease.The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging.Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo.Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases.Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons.Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains.Abnormal processing of tau in the brain of aged TgCRND8 mice.Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson's Disease: An In Situ Proximity Ligation Assay Study.Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System AtrophyLiving in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and PathologyNF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in miceStudy of alpha-synuclein fibrillation: state of the art and expectationsSynapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's diseaseThe good and bad of therapeutic strategies that directly target α-synucleinAbiraterone acetate exerts a cytotoxic effect in human prostate cancer cell linesNicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromerAlpha-Synuclein Preserves Mitochondrial Fusion and Function in Neuronal Cells
P50
Q24299645-25EF4E87-17FF-4ACB-914A-04D21CEDF862Q33944220-F1B7047E-0DD8-45F2-BA4B-FB6086B838BDQ35412397-06538EEF-B198-4008-BD42-D32EE2FFDFAAQ35627153-082BFBB8-89C5-429D-93DA-86526C67B84BQ36218699-F19CEC33-2E31-4E48-B085-F4B8BE505EECQ38007671-E7CD7FC3-A013-4C03-A851-8F4E40DBC223Q38306271-C2EB3685-05B4-44B9-9B59-1418109F0571Q38650395-95CED621-626E-4663-A8C0-AFBEE48C599AQ38890512-6BCB731D-DBB2-44DB-8661-7C618CCD3C70Q39108546-6A5C2F62-F7D4-411D-BBE5-33BEC0BA93AAQ39618931-24E20AAB-463F-41DC-9519-DAAE68D4A229Q40113108-11C5F8CD-A66F-46A7-95A2-FD0ED6B94B52Q41050568-CEA3454D-6F6B-4F4D-82F3-5701C6232227Q41895193-D8175802-89B5-47F9-B831-913EBDC50F3DQ42435199-C8E0410F-6A7F-42AE-AB4B-177197E8EDF5Q42476891-E5D9AA97-684D-4CFE-8E3E-4B4DBBAFFA37Q42496660-CB1F27BD-D0CA-4613-A83E-5C2755FD51D7Q42526679-E7D47587-7F4F-4D34-ADA1-2246B33F5B6AQ42700405-DDC69250-37A7-472D-8279-E14EC68995CFQ44059400-031BE7E7-0E33-4C6F-B8CB-681FA2526FA0Q44374035-2E780302-694A-451F-A4D9-607314CDE52FQ44632120-2FB0422E-B58C-4A82-8BF2-0D6B6781555CQ47239603-4B031223-43FB-48D0-A50B-AECF1CF30DD1Q47720283-E41EB599-0F21-4ADE-980E-1BEDE0049807Q47814609-DD5C8CA0-26F9-42E7-B603-3A6B04BC7BD9Q47866245-B233EDA7-72AD-472E-B1F8-F2A9D5513BAEQ48094292-B2D6CDAD-331C-483E-83E0-F46463C8AA59Q55715226-E91CD24C-9063-4B2B-A0C6-E16159ECED4AQ57818105-3A2142B2-BE09-428D-BD91-3718A291953FQ60922145-753D6C26-74CF-46B4-B7B4-31C4E96CB77BQ64276647-A00C739A-00D5-4AA1-B4EB-7196D665CA59Q90175415-DBD0A9C4-8616-4617-A40F-90003F657929Q90481576-00F1B4C7-0BFC-4891-9D73-17590681C410Q91143018-52313CE6-497A-4AF1-BB7B-28CA50470285Q91637730-BF6F93A7-AF81-4405-82A3-C377870B3801Q91733469-351596F4-5A01-4071-9A72-A0F1FF3600E4Q92220037-983F298F-D048-4DC6-A2EB-A53E47B56269
P50
description
researcher ORCID ID = 0000-0002-9581-1919
@en
wetenschapper
@nl
name
Arianna Bellucci
@ast
Arianna Bellucci
@en
Arianna Bellucci
@es
Arianna Bellucci
@nl
type
label
Arianna Bellucci
@ast
Arianna Bellucci
@en
Arianna Bellucci
@es
Arianna Bellucci
@nl
altLabel
Arianna BELLUCCI
@en
Bellucci A
@en
prefLabel
Arianna Bellucci
@ast
Arianna Bellucci
@en
Arianna Bellucci
@es
Arianna Bellucci
@nl
P1053
K-2063-2016
P106
P1153
7003345414
P2798
P31
P4012
P496
0000-0002-9581-1919